Novel inhibitor of hematopoietic cell kinase as a potential therapeutic agent for acute myeloid leukemia.
Roversi FM, Bueno MLP, da Silva JAF, Assis-Mendonça GR, Torello CO, Shiraishi RN, Pericole FV, Ferro KP, Duarte ASS, Rego EM, Saad STO.
Roversi FM, et al.
Cancer Immunol Immunother. 2022 Aug;71(8):1909-1921. doi: 10.1007/s00262-021-03111-2. Epub 2022 Jan 18.
Cancer Immunol Immunother. 2022.
PMID: 35039904
Free PMC article.